C-peptide (C-Peptide)

C-peptide is a small peptide fragment that is produced together with insulin in the cells of the pancreas. This biomolecule is an important component of the insulin synthesis process and plays a significant role in the diagnosis and monitoring of diabetes. Let's take a closer look at what C-peptide is, what its function is, and how it is used in medicine.

C-peptide is formed during the processing of proline-isoleucine-cysteine (proinsulin), which is a precursor to insulin. Proline-isoleucine-cysteine consists of three parts: insulin, C-peptide, and a peptide-like material (connecting peptide) that connects the two peptide fragments. After proinsulin is formed, it is cleaved in pancreatic cells by proteases into two separate fragments, insulin and C-peptide. Insulin then leaves the cell to lower blood glucose levels, while C-peptide remains in the blood for a while before being excreted by the kidneys.

The main function of C-peptide is to help insulin regulate blood glucose levels. Since C-peptide is produced in equal proportions with insulin, its level in the blood can serve as an indicator of the activity of insulin synthesis in the body. This makes it a useful biomarker for the diagnosis of various diseases, including diabetes.

In the diagnosis of diabetes mellitus, C-peptide is of great importance. Clinical analysis of the level of C-peptide in the blood can help the doctor determine whether the cause of hyperglycemia (elevated blood glucose levels) is due to insufficient secretion of insulin or its improper use by the body's cells. In the case of a diagnosis of type 1 diabetes, when insulin is not synthesized at all, the level of C-peptide will be very low. In type 2 diabetes, when insulin is not synthesized enough or the body's cells become less sensitive to insulin, the level of C-peptide will be moderate or even normal.

In addition to diagnosis, measuring C-peptide levels can be useful for monitoring the effectiveness of diabetes treatment. In patients with diabetes receiving insulin therapy, changes in C-peptide levels in the blood can indicate how well glucose levels are being controlled by insulin. A decrease in C-peptide levels may indicate inadequate treatment, while a stable or increasing level may indicate improvement in the condition.

In addition to diagnosing and monitoring diabetes, C-peptide testing also has important clinical applications in other pathologies. For example, testing C-peptide levels in the blood can help assess pancreatic function in patients with pancreatitis, as well as diagnose other rare pancreatic pathologies.

In conclusion, C-peptide is an important molecule that is produced together with insulin and plays an important role in regulating blood glucose levels. Measuring C-peptide levels may be useful for diagnosing and monitoring diabetes mellitus, as well as some other pancreatic diseases. Further research in this area may lead to an understanding of more precise applications of C-peptide in clinical practice and improved treatment of patients with various diseases.